Qube Research & Technologies LTD Eyenovia, Inc. Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Eyenovia, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 12,227 shares of EYEN stock, worth $21,274. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,227
Previous 19,451
37.14%
Holding current value
$21,274
Previous $10,000
90.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EYEN
# of Institutions
45Shares Held
5.68MCall Options Held
72.9KPut Options Held
36.3K-
Lasry Marc New York, NY2.45MShares$4.26 Million4.63% of portfolio
-
Geode Capital Management, LLC Boston, MA577KShares$1 Million0.0% of portfolio
-
Morgan Stanley New York, NY507KShares$882,3540.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA438KShares$762,6640.0% of portfolio
-
Citigroup Inc244KShares$423,9510.0% of portfolio
About EYENOVIA, INC.
- Ticker EYEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,212,900
- Market Cap $59.5M
- Description
- Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...